International pharmaceutical company focusing on essential medicines
“Our model prioritizes essential medicines, thereby preserving trusted tools for doctors and guaranteeing access to reliable treatments for patients.”
Frédéric Mascha
Founder and CEO of Juvisé Pharmaceuticals
Juvisé Pharmaceuticals in a few figures
80
countries where our medications are marketed
10
"princeps" medications
2.5
million patients treated each year
81%
of production located in Europe (51% in France)
30
manufacturing partners
25
pharmaceutical partners
80
countries where our medications are marketed
10
"princeps" medications
2.5
million patients treated each year
81%
of production located in Europe (51% in France)
30
manufacturing partners
25
pharmaceutical partners
Our therapeutic areas
Improving the health of millions of patients around the world
Media
Juvisé Pharmaceuticals acquires global rights (excluding US/Canada) to PONVORY® and opens its capital to Bpifrance and Pemberton Meet Frédéric Mascha, our Founder and President at Bpifrance BIG2023 on Thursday October 5 at the Accor Arena in Paris! 27th Annual Meeting of the Spanish Association of Gastroenterology (AEG) in Madrid, Spain 36th annual congress of the European Helicobacteur and Microbiota Study Group in Antwerp, BelgiumJUV-FRA-202408-0213, 09/2024